FDA Announces Flexibility on New Food Nutrition and Supplement Labeling Regulati
On September 18, 2020, FDA announced additional flexibility measures for manufacturers who need to comply with updated labeling requirements for nutrition and supplements by January 1, 2021. For manufacturers with less than $10 million in annual food sales, while the compliance date will remain in effect, FDA will not focus enforcement actions on these smaller food manufacturers during 2021. In addition, given that manufacturers may need more time to meet requirements during the new coronary period, the FDA is offering the same flexibility measures to companies with $10 million or more in annual sales that need to comply with nutrition and supplement labeling requirements by January 1, 2020.
Looking for chemical products? Let suppliers reach out to you!
Korea recognizes ginseng for bone health
2026-07-12
-
Functional Ingredients Industry Overview
Collection of Markets for Functional Ingredients in Food & Nutrition and Cosmetics.Published in: Mar. 2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
U.S. FDA plans to develop a new method for the determination of sulfite in food
-
ANVISA Updates Additive Rules
-
UK Proposes Sharp Increase in MRL for Flubendiamide in Tea
-
Singapore Suspends Poultry Imports from Avian Flu-Affected Areas in Japan
-
EFSA Finds L-Cysteine Feed Additives Safe for All Animal Species
-
EFSA Confirms Safety of Triacylglycerol Lipase for Expanded Food Uses
-
EFSA Reports Avian Influenza Situation in Europe and Human Cases in Asia
-
EFSA Renews Authorisation of Inositol for Use in Fish and Crustacean Feed
-
EFSA Approves Cellulase from GM Aspergillus Niger with Low Allergy Risk
-
Canada Launches Re-Evaluation of Herbicide Iodosulfuron-Methyl-Sodium
Recommend Reading
-
EU Authorises Propionic Acid and Its Salts as Feed Additives Until 2035
-
From Desert Sands to Dining Tables: Arab Food & Beverage Sector Emerges as Investment Powerhouse
-
EU Greenlights Four GM Crops—But Only at the Border
-
EU Officially Approves Rapeseed Oil as a Low-Risk Active Substance Until 2040
-
EFSA Confirms Safety of β-Amylase Produced from Barley for Food Manufacturing Use
-
U.S. Health Chief Says No Evidence Linking Tylenol to Autism
-
Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy
-
August Hydrofluoric Acid Market Prices Continue to Show Weak Performance in China
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
-
Supply-Demand Game, Dichloromethane Under Pressure and Declining